Impact and cost-effectiveness of smoking interventions

The American Journal of Medicine

Volumn 93, Issue 1 SUPPL. 1, 1992, Pages

  Tsevat, Joel ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FORECASTING; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; MORTALITY; REVIEW; SMOKING; SMOKING CESSATION;

ADULT; AGED; CORONARY DISEASE; COST-BENEFIT ANALYSIS; FEMALE; FORECASTING; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION;

EID: 13744265071     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(92)90627-N     Document Type: Article

References (35)

1. The health benefits of smoking cessation: a report of the surgeon general
2. Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model
3. Relative impact of targeted versus population-wide cholesterol interventions on the incidence of coronary heart disease: projections of the Coronary Heart Disease Policy Model
4. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension
5. Long-term impact of smoking cessation on the incidence of coronary heart disease: projections of the Coronary Heart Disease Policy Model
6. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease
7. Expected gains in life expectancy from various coronary heart disease risk factor modifications
8. The Framingham Study: an epidemiological investigation of cardiovascular disease
9. The Framingham Study: an epidemiological investigation of cardiovascular disease
10. Trends in the incidence of myocardial infarction and in associated mortality and morbidity in a large employed population
11. Estimates of the civilian population of the United States by age, sex, and race: 1980–1983
12. Preliminary estimates of the population of the United States by age, sex, and race, 1970–1981
13. Projections of the population of the United States by age, sex, and race: 1982–2050
14. Life expectancy of American men in relation to their smoking habits
15. Health and economic implications of a tobacco-free society
16. Smoking-attributable mortality and years of potential life lost—United States 1988
17. Smoking and life expectancy among U.S. Veterans
18. A catalog of risks
19. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking
20. Cholesterol reduction and life expectancy: a model incorporating multiple risk factors
21. Effects of coronary risk reduction on the pattern of mortality
22. Smoking: health effects and control
23. Reducing the health consequences of smoking: 25 years of progress
24. Cigarette smoking and the risk of endometrial cancer
25. Smoking cessation and severity of weight gain in a national cohort
26. The cost-effectiveness of counseling smokers to quit
27. Long-term use of nicotine vs placebo gum
28. Long-term use of nicotine chewing gum: occurrence, determinants, and effect on weight gain
29. Dependence potential and abuse liability of nicotine replacement therapies
30. Screening for cervical cancer
31. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection